论文部分内容阅读
目的：考查中药抗癌剂复方莪术油肝动脉栓塞治疗肝癌的疗效和意义。材料与方法：用莪术油、鸦胆子油和碘油配制成复方莪术油，经肝动脉栓塞治疗８４例原发性肝癌。结果：治疗后肿瘤平均缩小率３９．２％。１、２、３年生存率分别为８０％、４３．４％和２４％。无因治疗引起肝功恶化和骨髓抑制现象。部分患者治疗后肝功能明显改善。结论：复方莪术油作为一种新的中药肝动脉栓塞剂，治疗肝癌具有肯定的疗效。这种油性中药制剂具有抗癌、低毒、栓塞和留滞于肿瘤局部的突出特点。这些特点使它有很大的优势成为肝癌介入治疗的较为理想的栓塞剂
Objective: To investigate the curative effect and significance of traditional Chinese medicine anti-cancer agent compound zedoary arterial hepatic artery embolization in the treatment of liver cancer. Materials and Methods: Compound Rhizoma Curcumae Oil was formulated with Rhizoma Curcumae Oil, Brucea javanica Oil and Lipiodol, and 84 patients with primary liver cancer were treated with hepatic artery embolization. Results: The average reduction rate of tumors after treatment was 39.2%. The 1-, 2-, and 3-year survival rates were 80%, 43.4%, and 24%, respectively. No treatment resulted in liver function deterioration and myelosuppression. Some patients have improved liver function after treatment. Conclusion: Compound zedoary oil as a new Chinese medicine hepatic arterial embolization agent has a positive effect on the treatment of liver cancer. This oily Chinese medicine preparation has prominent features of anti-cancer, low toxicity, embolism, and retention in the tumor. These characteristics make it a great advantage as an ideal embolic agent for interventional treatment of liver cancer.